Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Reed Smith (Worldwide) ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Munich Regional Court Clarifies When Claims For Transfers Of Patents Become Time-Barred
Germany is one of the most important patent litigation jurisdictions in Europe, making developments in its patent law very important to life sciences companies
UK
3 Jul 2019
2
China Continues To Sharpen Its Teeth Against Corruption: Updates To China's Anti-Corruption Regime
The first half of 2018 saw a number of significant changes to the Chinese anti-corruption regime, including amendments to the Anti-Unfair Competition Law and formation of new anti-corruption regulatory bodies.
China
18 Sep 2018
3
Brexit And The Pharmaceuticals Sector: The Key Issues
The United Kingdom (UK) is scheduled to leave the European Union on 29 March 2019. Certain key aspects of the Brexit deal now seem to have been agreed upon
European Union
6 Sep 2018
4
Major Medical Device Changes In China Introduced By The 2018 Draft Amendment To The "Regulations On The Supervision And Administration Of Medical Device"*
Following the issuance of the "Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation in the Industries of Pharmaceuticals and Medical Devices"
China
16 Aug 2018
5
Germany – A Major Hub For Patent Litigation
With the Unified Patent Court now stalled for at least the near future, U.S. life sciences companies will continue to face the question of where to bring patent infringement cases in Europe.
Germany
2 Aug 2017
6
New Regulations Reshape Transparency-Related Obligations In France, Could Impact Life Sciences Companies
In France, transparency requirements are regulated by two main sets of laws: "The French Anti-Gift Law" . . .
France
22 Mar 2017
7
Again The Life Science Industry Will Have To Take A Close Look At A New Set Of Regulations Reshaping Transparency-Related Obligations
Article body Current Length: 9407 chars Long including spaces Source Preview The relationship between the life sciences industry and health-care practitioners is being reshaped in France through regulatory developments under both the French Anti-Gift Law and the French Sunshine Act.
France
20 Mar 2017
8
European Patent Litigation For Life Sciences Companies: A Silver Lining To The Brexit Cloud?
The introduction of the Unified Patent Court (UPC) is undoubtedly the most significant change to the European patent landscape since the European Patent Convention of 1973.
UK
26 Sep 2016
9
What Brexit Means For Data Protection
If the UK exits the EU before the GDPR comes into force, it will not be without a data protection law.
European Union
6 Jul 2016
10
European Patent Office to Make Pan-European Revocation Proceedings Faster, More Efficient as of July 1
European Patent Office oppositions are a very powerful way of litigating newly granted patents.
UK
22 Jun 2016
11
New Edition Of Singapore International Arbitration Centre Rules To Come Into Effect Shortly
Pharmaceutical and medical device manufacturers are increasingly finding themselves resolving disputes through international arbitration.
Singapore
9 Jun 2016
12
French Bribery Act Would Be Anti-Corruption Revolution
We've covered the French Sunshine Act, which requires French pharmaceutical companies to disclose their links to healthcare providers, extensively over the past few years.
France
29 Feb 2016
13
Upcoming Reed Smith Webinar On Cross-Border E-Discovery & New Ruling Regarding The US-EU Safe Harbor Framework
The Reed Smith Life Sciences Health Industry (LSHI) Group will be hosting an upcoming webinar "Cross-Border E-Discovery & New Ruling Regarding the US-EU Safe Harbor Framework" on November 24, 2015 ..
Worldwide
2 Nov 2015
14
Amarin Pharma v. FDA – More Briefs Filed Regarding Off-Label Promotion And The First Amendment
Our prior posts looked at the Amarin Pharma, Inc. v. United States Food and Drug Administration lawsuit, which raises issues regarding the First Amendment and how it applies to speech by drug and device manufacturers regarding "off-label" uses.
UK
4 Jul 2015
15
In-House Lawyers In France Remain Without Legal Privilege
"Projet de loi Macron," a bill recently introduced by French Minister for Economic Affairs Emmanuel Macron, proposed the recognition of legal privilege for in-house lawyers in France.
France
16 Mar 2015
16
Public Consultation Examines Potential Confidentiality Issues with New European Clinical Trial Regulations
The public consultation concludes today (February 18), with results of the consultation being published thereafter.
European Union
19 Feb 2015
17
European Clinical Trial Regulations Public Consultation – Confidentiality Concerns
Clinical Trial Regulations On 21 January 2015, the European Medicines Agency (EMA) began a public consultation on the new European Clinical Trial Regulations (CTRs).
European Union
18 Feb 2015
18
The French Sunshine Act: Towards Simplification And New Deadlines?
Similar to the U.S. Sunshine Act, the French Sunshine Act made mandatory the publication of benefits granted by pharmaceutical laboratories to health professionals.
France
2 Jun 2014
19
UK Government Addresses Lack Of Regulation And Legislation In Cosmetics Industry
An independent review of the regulation of cosmetic interventions in the UK highlights an insufficient amount of regulation in the industry.
UK
16 Apr 2014
20
EU Research Group Condemns EU Regulation For Restricting Growth In Life Sciences Sector; NHS Advocates Selling Confidential Patient Data For Secondary Purposes
Reed Smith’s Global Regulatory Enforcement Law blog features two posts of interest to those in the life sciences industry, both written by Reed Smith partner Cynthia O’Donoghue. " EU Research Group Condemns EU Regulation for Restricting Growth in Life Sciences Sector" discusses the opposition of a lobbying group ...
UK
22 Feb 2014
Links to Result pages
 
1 2  
>>Next